These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38310388)

  • 1. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas.
    Zhang Z; Wang C; Shi W; Wang Z; Fu W
    Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning based intratumor heterogeneity signature for predicting prognosis and immunotherapy benefit in stomach adenocarcinoma.
    Chen H; Zheng Z; Yang C; Tan T; Jiang Y; Xue W
    Sci Rep; 2024 Oct; 14(1):23328. PubMed ID: 39375438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtypes and Prognostic Models for Predicting Prognosis of Lung Adenocarcinoma based on MiRNA-related Genes.
    Wei Y; Zhong W; Bi Y; Liu X; Zhou Q; Liu J; Wang M; Zhang H; Chen M
    Curr Med Chem; 2024; 31(34):5620-5637. PubMed ID: 37711127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a circular RNA-microRNA-messengerRNA regulatory network in stomach adenocarcinoma.
    Liu Q; Zhang W; Wu Z; Liu H; Hu H; Shi H; Li S; Zhang X
    J Cell Biochem; 2020 Feb; 121(2):1317-1331. PubMed ID: 31486138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a novel prognostic signature in gastric adenocarcinoma.
    Mao R; Wang Z; Zhang Y; Chen Y; Liu Q; Zhang T; Liu Y
    Aging (Albany NY); 2020 Nov; 12(21):22233-22252. PubMed ID: 33188157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    PeerJ; 2024; 12():e16776. PubMed ID: 38274323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
    Chen Z; Cheng G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):666-680. PubMed ID: 37691229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
    Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
    World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of necroptosis-associated miRNA signature for predicting prognosis and immune landscape in stomach adenocarcinoma.
    Zhang S; Liu S; Yue C; Liu Y; Zheng G; Zhang Y
    Exp Cell Res; 2024 Mar; 436(1):113948. PubMed ID: 38307189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.